New World Angels — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Aegle Therapeutics develops therapies using extracellular vesicles (EVs) isolated from mesenchymal stem cells to deliver therapeutic biomolecules to diseased and damaged cells.
BiotechHealthtechMedical DevicesWoburn, US
Evangelos Badiavas(Director)Shelley A. Hartman(Co-founder & CEO)inEvangelos V. Badiavas(Founder & Chief Scientific Officer)Heidi Kempinski(Chief Operational Officer)Kathleen Murphy(Head of Clinical Operations)Shelley Hartman(Executive Officer, Director)
Co-investorsDEFTA PartnersOcean Azul Partners
Nanopattern Technologies is a company focused on nanopatterning, with a team including chemists, researchers, and engineers working on materials and related technology.
Deep TechHardwareNew MaterialsSemiconductorsChicago, US
Yu Kambe(CEO & Cofounder)inDanielle Chamberlin(CTO)Forrest Etheridge(COO)Dmitri Talapin(Cofounder)
Co-investorsService Provider Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.